Skip to main content
. 2014 Jan 15;35(6):1320–1329. doi: 10.1093/carcin/bgu011

Fig. 2.

Fig. 2.

Oral administration of GE exhibited enhanced inhibition of human prostate tumor xenograft growth in nude mice compared with Mix. Male nude mice were subcutaneously injected with 106 PC-3-luc cells. (A) Representative bioluminescent images of one animal per group indicating progression of tumor growth over 4 weeks. (B) Graphical representation of quantitative radiance measured as the number of photons leaving a square centimeter of tissue and radiating into a solid angle of 1 steradian (photons/sec/cm2/sr) from control vehicle, GE- and Mix-fed mice for 4 weeks. (C) Tumor growth monitored (by vernier calipers) and presented as tumor volume in cubic millimeter, over a period of 4 weeks. (D) Graphical representation of body weight of vehicle, GE- and Mix-treated mice. (E) Graphical representation of tumor weight. (F) Representative photographic images of excised tumors [*P < 0.05 (two-way analysis of variance), as compared with controls; B, C and E]. Error bars refer to ±SD. Statistical significance in percent tumor growth between control and treatment groups was achieved after week 3.